The DNA binding and accumulation of p53 from breast cancer cell lines and the link with serine 15 phosphorylation

被引:17
|
作者
Ray, Debolina [1 ]
Murphy, Keith R. [1 ]
Gal, Susannah [1 ]
机构
[1] SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13901 USA
关键词
post-translational modifications; phosphorylation; stabilization; cell cycle regulation; apoptosis; WILD-TYPE P53; TUMOR-SUPPRESSOR PROTEIN; MUTANT P53; DOWN-REGULATION; ACTIVATION; EXPRESSION; MUTATIONS; GROWTH; NEUROBLASTOMA; ACETYLATION;
D O I
10.4161/cbt.20835
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Stress treatment generally causes the post-translational modification and accumulation of the p53 protein, although the role of these aspects has not been always understood in relation to this protein's tumor suppressor activity. We analyzed these attributes of p53 in eight different breast cancer cell lines, with either wild-type or mutant p53 protein, in response to oxidative stress. We found that the wild-type p53 protein from MCF-7 and ZR-75-1 cells binds with different affinity to 12 gene sequences covering several pathways regulated by p53. Treatment of MCF-7 cells with H2O2 caused an increase in this binding affinity while this same treatment of ZR-75-1 cells caused the p53 protein to lose binding affinity to several genes. The mutant p53 proteins from all cell lines had minimal to weak binding to these sequences even after treatment with H2O2. The p53 protein from the ZR-75-1 cells and three cell lines with mutant p53 showed serine 15 phosphorylated protein, but we found no correlation between that modification and the levels or localization of this protein although DNA binding affinity of wild-type protein might be affected by this modification. From this and other work, it appears that the mutation status of the TP53 gene alone cannot predict the activity of this tumor suppressor since cell lines with the same genetic information do not show the same properties of this protein.
引用
收藏
页码:848 / 857
页数:10
相关论文
共 50 条
  • [1] Differences in the levels, localization and DNA binding of p53 in breast cancer cell lines
    Ray, Debolina
    Murphy, Keith R.
    Gal, Susannah
    CANCER RESEARCH, 2012, 72
  • [2] Phosphorylation of p53 serine 15 increases interaction with CBP
    Lambert, PF
    Kashanchi, F
    Radonovich, MF
    Shiekhattar, R
    Brady, JN
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) : 33048 - 33053
  • [3] The association between p53 protein phosphorylation at serine 15, serine 20 and sensitivity of cells isolated from patients with ovarian cancer and cell lines to chemotherapy in in vitro study
    Iwona Kamińska
    Julia K. Bar
    Pharmacological Reports, 2018, 70 : 570 - 576
  • [4] The association between p53 protein phosphorylation at serine 15, serine 20 and sensitivity of cells isolated from patients with ovarian cancer and cell lines to chemotherapy in in vitro study
    Kaminska, Iwona
    Bar, Julia K.
    PHARMACOLOGICAL REPORTS, 2018, 70 (03) : 570 - 576
  • [5] p53 Mutation in Inflammatory Breast Cancer Cell Lines
    Li, C.
    Lee, B-N
    Woodward, W. A.
    Ueno, N. T.
    Robertson, F.
    Reuben, J. M.
    Cristofanilli, M.
    CANCER RESEARCH, 2009, 69 (24) : 699S - 700S
  • [6] Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215
    Li, QY
    Kaneko, S
    Yang, L
    Feldman, RI
    Nicosia, SV
    Chen, JD
    Cheng, JQ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (50) : 52175 - 52182
  • [7] Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line
    Lin, HY
    Shih, A
    Davis, FB
    Tang, HY
    Martino, LJ
    Bennett, JA
    Davis, PJ
    JOURNAL OF UROLOGY, 2002, 168 (02): : 748 - 755
  • [8] Time and dose-dependent activation of p53 serine 15 phosphorylation among cell lines with different radiation sensitivity
    Wittlinger, Michael
    Grabenbauer, Gerhard G.
    Sprung, Carl N.
    Sauer, Rolf
    Distel, Luitpold V. R.
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2007, 83 (04) : 245 - 257
  • [9] MUTATION OF THE SERINE 15 PHOSPHORYLATION SITE OF HUMAN P53 REDUCES THE ABILITY OF P53 TO INHIBIT CELL-CYCLE PROGRESSION
    FISCELLA, M
    ULLRICH, SJ
    ZAMBRANO, N
    SHIELDS, MT
    LIN, D
    LEESMILLER, SP
    ANDERSON, CW
    MERCER, WE
    APPELLA, E
    ONCOGENE, 1993, 8 (06) : 1519 - 1528
  • [10] TRANSACTIVATIONAL AND DNA-BINDING ABILITIES OF ENDOGENOUS P53 IN P53 MUTANT-CELL LINES
    PARK, DJ
    NAKAMURA, H
    CHUMAKOV, AM
    SAID, JW
    MILLER, CW
    CHEN, DL
    KOEFFLER, HP
    ONCOGENE, 1994, 9 (07) : 1899 - 1906